Medical network - April 19 medical insurance directory of eight years of protection or will become history. 

 

▍ medicare catalog build exit mechanism 

 

Yesterday (18), people club department website "about open for establishing the basic medical insurance, inductrial injury insurance and maternity insurance drug catalogue dynamic adjustment mechanism announcement concerning the opinion suggestion, including" exit mechanism "medicare drugs directory drugs caused widely attention. 

 

Released in February 2017, the new national health insurance directory, update than in the previous edition in 2009, eight years apart. 

 

Because the hospital long-term occupied 80% of total sales of the domestic pharmaceutical market share, for any one pharmaceutical companies, medical insurance directory and the huge market. 

 

Into the health care means that stable sales, continued market coverage, and hence profits growth - a spread in anecdotal, a drug into not into the medical insurance directory, 10 times sales may differ. 

 

Also as a result, medical insurance directory has been shortlisted all including multinational pharmaceutical companies, pharmaceutical companies most competitive key battleground, also most entanglements of interest area, news about directory in the high medical market all nerves, into the health care means that the largest market stable sales guarantee, but not yet into medical insurance directory, will expect a seating in the new medical insurance directory changes and new market space. 

 

Then, in 2009 to 2017, eight years, almost every few years has news about medical insurance directory will be updated from the so-called "close to the authorities", but ultimately did not come true. 

 

▍ medicine make room to innovation 

 

Talk in May 2016, the market has been a long time of health talks started, is considered to be the new health insurance directory entered the countdown signals. 

 

The first batch of national health insurance directory negotiations, first-line treatment chronic hepatitis b drug tenofovir ester, non-small cell lung cancer targeted therapy drugs for ek, a reduction to the treatment and the three drugs were 67%, 67% and 67%; In contrast, negotiated before, tenofovir ester, ek for the treatment and the cost price of as high as 1500 yuan, 12000 yuan and 15000 yuan respectively. 

 

And the health care catalogs sensibility was announced in March this year, with all over the country, the health care to realize a butt joint around the public can be implemented in accordance with the local expenses standards first expensive medicine expenses. 

 

Recently, the second batch of drugs being sold on the open 44 varieties of negotiations, according to the plan, ultimately through the shortlisted varieties will have access to health care to pay, is also considered medical insurance directory to "dynamic adjustment" trademark information. 

 

Held recently in nanjing, "2017 international conference on medical innovation", the Chinese chemical pharmaceutical industry association Pan Guangcheng "blue parker, media interview, said to adjust the normalized medical insurance directory, a adjustment over the past seven years, a lot of medicine into less than health insurance directory, a biennial innovative drugs shall be normalized, and commercial insurance should vigorously promote in China. 

 

He also suggested that, during the period of "twelfth five-year", a class of new drugs developed has 15 suggest these kind of new drugs can enter the health care through the price negotiation, some even can be automatically entered into medicare catalog, so that the whole health care structure more reasonable, improve the level of public administration, also encourage domestic new drugs development. 

 

Former President of the Chinese pharmaceutical enterprise management association ming-de yu also think that this innovation medicine should be automatically entered into medical insurance directory, if the tension, can cut pay scale, inspire new drug innovation. 

 

And compared to the past often update period in 78, the market is no longer keep years of "stability" pattern - dynamic adjustment means that the enterprise will face all kinds of challenges in the market, to be eliminated, being squeezed out, everything will become possible. 

 

The attached: 

 

About open for establishing the basic medical insurance, inductrial injury insurance and maternity insurance drug catalogue dynamic adjusting mechanism about the comments 

 

To better safeguard the rights and interests of the ginseng protect personnel to primary medical treatment, to meet the needs of actual clinical application and support to promote the development of medical technology innovation, according to the law of the People's Republic of China social insurance law "and other laws and regulations, human resources and social security ministry plans to jointly with relevant departments to study this year improve the basic medical insurance, inductrial injury insurance and maternity insurance drug administration policy, gradually establish a drug catalogue dynamic adjustment mechanism. For the opinions of the parties have been heard, presently faces the society widely solicit to establish and improve the basic medical insurance, inductrial injury insurance and maternity insurance drug catalogue (hereinafter referred to as "medicare drug directory) dynamic adjustment mechanism and advice. Welcome to research institutions, academic organizations, experts and scholars as well as the social people from all walks of life to participate in, mainly around the following questions, please view and give reasons. 

 

A, dynamic adjusting medicare drug directory how to balance both clinical demand, support innovation and medical insurance fund. 

 

Second, health care drugs directory dynamic adjustment range, the newly approved drugs, patent medicine, non-exclusive variety, catalog listed varieties and what measures should be taken and rules. 

 

Three, health care drugs directory dynamic adjustment of how to implement the parties appeal adequately express, how to make full use of drugs such as economics evaluation means, how to use the objective data to support expert evaluation mechanism. 

 

Four negotiations, health care drugs directory access mechanism is how to build, how to determine the effective period of negotiation result, how to pay standards. 

 

Five, how to realize the drug registration for examination and approval, production circulation, clinical application, such as health care payment link of effective connection. 

 

6, how to set up health care drugs directory drugs exit mechanism.